<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SCTPN</title>
	<atom:link href="http://www.sctpn.net/1viralvoice/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.sctpn.net/1viralvoice</link>
	<description>#1ViralVoice for Sickle Cell Awareness</description>
	<lastBuildDate>Fri, 24 May 2013 22:31:04 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
		<item>
		<title>Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From &#8230;</title>
		<link>http://www.sctpn.net/1viralvoice/blog/2013/05/24/sangamo-biosciences-receives-6-4-million-strategic-partnership-award-from-2/</link>
		<comments>http://www.sctpn.net/1viralvoice/blog/2013/05/24/sangamo-biosciences-receives-6-4-million-strategic-partnership-award-from-2/#comments</comments>
		<pubDate>Fri, 24 May 2013 22:31:04 +0000</pubDate>
		<dc:creator>diradiocast</dc:creator>
				<category><![CDATA[Sickle Cell News Post]]></category>
		<category><![CDATA[re-post]]></category>

		<guid isPermaLink="false">http://www.sctpn.net/1viralvoice/blog/2013/05/24/sangamo-biosciences-receives-6-4-million-strategic-partnership-award-from-2/</guid>
		<description><![CDATA[RICHMOND, Calif., May 24, 2013 /PRNewswire via COMTEX/ &#8211; Sangamo BioSciences, Inc. /quotes/zigman/82231/quotes/nls/sgmo SGMO +0.63% announced that the California Institute for Regenerative Medicine (CIRM) has granted the Company a $6.4 million Strategic Partnership Award to develop a potentially curative ZFP Therapeutic for beta-thalassemia based on the application of its zinc finger nuclease (ZFN) gene-editing technology [...]]]></description>
		<wfw:commentRss>http://www.sctpn.net/1viralvoice/blog/2013/05/24/sangamo-biosciences-receives-6-4-million-strategic-partnership-award-from-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Sangamo BioSciences Receives $6.4 Million Strategic Partnership Award From &#8230;</title>
		<link>http://www.sctpn.net/1viralvoice/blog/2013/05/24/sangamo-biosciences-receives-6-4-million-strategic-partnership-award-from/</link>
		<comments>http://www.sctpn.net/1viralvoice/blog/2013/05/24/sangamo-biosciences-receives-6-4-million-strategic-partnership-award-from/#comments</comments>
		<pubDate>Fri, 24 May 2013 16:30:12 +0000</pubDate>
		<dc:creator>diradiocast</dc:creator>
				<category><![CDATA[Sickle Cell News Post]]></category>
		<category><![CDATA[re-post]]></category>

		<guid isPermaLink="false">http://www.sctpn.net/1viralvoice/blog/2013/05/24/sangamo-biosciences-receives-6-4-million-strategic-partnership-award-from/</guid>
		<description><![CDATA[RICHMOND, Calif., May 24, 2013 /PRNewswire/ &#8211; Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced that the California Institute for Regenerative Medicine (CIRM) has granted the Company a $6.4 million Strategic Partnership Award to develop a potentially curative ZFP Therapeutic for beta-thalassemia based on the application of its zinc finger nuclease (ZFN) gene-editing technology in hematopoietic stem cells [...]]]></description>
		<wfw:commentRss>http://www.sctpn.net/1viralvoice/blog/2013/05/24/sangamo-biosciences-receives-6-4-million-strategic-partnership-award-from/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
